Evolve Manufacturing Inc., a leading provider of end-to-end contract manufacturing services for medical device and life sciences instrument companies, proudly celebrates its fifth year of participation in ISACA’s Voluntary Improvement Program (VIP), as one of only two contract manufacturing companies to join this prestigious initiative. As one of the earliest participants in the program, Evolve continues to demonstrate its leadership in the medical device sector, and its commitment to supporting healthcare innovation.
VIP is part of the Medical Device Discovery Appraisal Program (MDDAP), which aims to enhance the quality, reliability, and efficiency of medical device supply chains while fostering stronger relationships between manufacturers and regulatory bodies.
As a trusted partner in medical device manufacturing, Evolve Manufacturing’s inclusion in VIP over the last five years highlights its commitment to innovation, quality, and patient safety. Leveraging ISACA’s tailored Capability Maturity Model Integration (CMMI) framework, Evolve will implement advanced practices that enable better management of supply chain challenges, improve organizational performance, and deliver safer, higher-quality products to market faster.
“We are honored to be part of ISACA’s Voluntary Improvement Program,” said Matt Pawluk, Vice President of Quality & Customer Relations at Evolve Manufacturing. “This collaboration reinforces our dedication to continuous improvement and ensures we remain at the forefront of quality and innovation in the medical device industry.”
Key Benefits of Evolve’s Participation in VIP:
- Enhanced Supply Chain Management: By adopting VIP’s globally accepted maturity model, Evolve will strengthen its ability to identify and mitigate risks, ensuring reliable and secure supply chains.
- Accelerated Innovation: Participation in VIP provides regulatory opportunities, such as streamlined inspection processes and faster approvals for changes, allowing Evolve to bring advanced medical devices to market more quickly.
- Improved Quality and Safety: Through data-driven insights and best practices, Evolve will achieve continuous improvements that enhance patient outcomes and operational excellence.
VIP was developed through a collaboration among the U.S. Food and Drug Administration (FDA), the Medical Device Innovation Consortium (MDIC), ISACA, and leading medical device manufacturers. The program empowers participants to go beyond compliance, setting new standards for quality and performance in the industry.
For more information about Evolve Manufacturing and its services, visit www.evolvemfg.com.
